AIRAmed GmbH

Change something! That's what drives us. Our goal? To make medical care for the entire spectrum of neurodegenerative diseases even better in the future.

That is why we put our heart and soul and our expertise from more than 20 years of university clinical experience into the development of innovative software solutions based on neural networks. They add a decisive factor to existing radiological reporting - objective measurability.

Around 64.8 million people worldwide are currently affected by dementia. This makes dementia the second most feared disease in society after cancer. This makes it all the more important to develop quantitative software solutions that enable early detection of this and other neurodegenerative diseases, including Alzheimer's, Parkinson's and multiple sclerosis. For an overall better medicine in the future, for the benefit of the patient.

The name AIRAmed stands for precision, innovation, the latest scientific findings and above-average service awareness.